SELVAS HEALTHCARE, INC. SELVAS Healthcare, Inc. Share Price
Equities
A208370
KR7208370007
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,735 KRW | +1.07% |
|
+1.61% | -30.67% |
| Sales 2022 | 27.69B 20.32M 1.69B | Sales 2023 | 29.81B 21.88M 1.83B | Capitalization | 175B 129M 10.73B |
|---|---|---|---|---|---|
| Net income 2022 | 2.65B 1.95M 162M | Net income 2023 | 5.17B 3.79M 317M | EV / Sales 2022 | 1.66 x |
| Net Debt 2022 | 771M 566K 47.23M | Net cash position 2023 | 21.04B 15.44M 1.29B | EV / Sales 2023 | 5.17 x |
| P/E ratio 2022 |
23.2
x | P/E ratio 2023 |
31.9
x | Employees | 110 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 59.34% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.07% | ||
| 1 week | +1.61% | ||
| Current month | -0.63% | ||
| 1 month | -11.16% | ||
| 3 months | -23.26% | ||
| 6 months | -40.52% | ||
| Current year | -30.67% |
1 week
4 640.00
4 840.00
1 month
4 525.005 300.00
Current year
4 525.007 460.00
1 year
4 525.0013 090.00
3 years
1 730.0014 090.00
5 years
1 395.0014 090.00
10 years
1 395.0014 090.00
| Managers | Title | Age | Since |
|---|---|---|---|
Byeong-Tak Yoo
CEO | Chief Executive Officer | 50 | 31/16/31 |
Young-Gul Kim
BRD | Director/Board Member | 56 | 01/17/01 |
Sang-Heon Lee
AUD | Comptroller/Controller/Auditor | 50 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Min-Cheol Kwak
BRD | Director/Board Member | 49 | 01/16/01 |
Byeong-Tak Yoo
CEO | Chief Executive Officer | 50 | 31/16/31 |
Jae-Ho Kim
BRD | Director/Board Member | 49 | 08/19/08 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/24/03 | 4,735 | +1.07% | 119,674 |
| 02/24/02 | 4,685 | -1.68% | 71,364 |
| 30/24/30 | 4,765 | +0.32% | 87,334 |
| 29/24/29 | 4,750 | +1.93% | 113,252 |
| 26/24/26 | 4,660 | -1.79% | 168,306 |
End-of-day quote Korea S.E., May 03, 2024
More quotes
Selvas Healthcare Inc is a Korea-based company principally engaged in the manufacture and sale of medical devices. The Company is engaged in the manufacture and sale of body composition measuring instruments, blood pressure monitors, braille information terminals and other digital healthcare products. In addition, the Company is engaged in the development and sale of healthcare software. The Company was established in 1993.
Calendar
14/05/2024
- Q1 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -30.67% | 89.68M | |
| +7.84% | 218B | |
| +7.35% | 184B | |
| +13.04% | 135B | |
| +26.03% | 107B | |
| -1.33% | 62.38B | |
| +11.80% | 51.37B | |
| +4.81% | 50.9B | |
| +0.30% | 40.87B | |
| +2.78% | 36.28B |
- Stock Market
- Equities
- A208370 Stock
